In the News

105 News Items found
Participants in Cycle for Survival
Treating Rare Cancers
Memorial Sloan Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers.
Luc Morris
Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood tests and clinical data.
Physician-scientist Luc Morris
In the Lab
MSK researchers shed light on how the number of mutations in a tumor affect a patient’s response to immunotherapy drugs.
Michelle Bradbury
Memorial Sloan Kettering researchers will explore "C dots" for tumor detection and treatment.
Doctors operating
On June 7 when Memorial Sloan Kettering opened a facility housing the novel Center for Image-Guided Interventions, a suite of endoscopy rooms, and new operating rooms for the Surgical Day Hospital.